Target intelligence / Profile preview

Arf-GAP domain and FG repeat-containing protein 2 (AGFG2)

Target
AGFG2
Molecular classification
ArfGAP protein family, Other
01

Overview

Arf-GAP domain and FG repeat-containing protein 2 (AGFG2) is a mammalian member of the ArfGAP protein family, containing a zinc-finger Arf-GAP domain, several phenylalanine-glycine (FG) repeats, and asparagine-proline-phenylalanine (NPF) motifs[3]. AGFG2 regulates vesicular trafficking, particularly by facilitating the stimulation-dependent exocytosis of von Willebrand factor (vWF) from Weibel–Palade bodies in endothelial cells upon exposure to phorbol ester or histamine[1][2][3]. It interacts with Eps15 homology (EH) domains and plays a role in the Rev export pathway, which mediates the nucleocytoplasmic transfer of proteins and RNAs[3]. AGFG2 is also highly expressed in the salivary gland and may contribute to exocytosis in other secretory cells. It has been identified as a host factor that influences HIV-1 progression, suggesting potential broader relevance in viral replication or immune response modulation[1][2][3].

Other names
AGFG2HRBLRABRHIV-1 Rev-binding protein-like proteinRev/Rex activation domain-binding protein relatedarf-GAP domain and FG repeat-containing protein 2nucleoporin
02

Biological functions

Regulation of vesicular traffickingFacilitating exocytosis of von Willebrand factor (vWF)Cargo sortingParticipating in nuclear-cytoplasmic transport (HIV-1 Rev pathway)
03

Disease associations

Infection (implicated in HIV-1 nuclear export[3])Other (potential relevance in vascular/secretory cell function[1][2][3])

Beyond the preview

Go deeper on Arf-GAP domain and FG repeat-containing protein 2 (AGFG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Arf-GAP domain and FG repeat-containing protein 2 (AGFG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call